Serum Her-2 marker, breast cancer and trastuzumab (Herceptine®) (Französisch)
- Neue Suche nach: Bethune-Volters, A.
- Neue Suche nach: Guepratte, S.
- Neue Suche nach: Labroquere, M.
- Neue Suche nach: Hacene, K.
- Neue Suche nach: Neumann, R.
- Neue Suche nach: Carney, W.
- Neue Suche nach: Pichon, M.-F.
- Neue Suche nach: Bethune-Volters, A.
- Neue Suche nach: Guepratte, S.
- Neue Suche nach: Labroquere, M.
- Neue Suche nach: Hacene, K.
- Neue Suche nach: Neumann, R.
- Neue Suche nach: Carney, W.
- Neue Suche nach: Pichon, M.-F.
In:
IMMUNOANALYSE ET BIOLOGIE SPECIALISEE
;
19
;
250-254
;
2004
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Serum Her-2 marker, breast cancer and trastuzumab (Herceptine®)
-
Beteiligte:Bethune-Volters, A. ( Autor:in ) / Guepratte, S. ( Autor:in ) / Labroquere, M. ( Autor:in ) / Hacene, K. ( Autor:in ) / Neumann, R. ( Autor:in ) / Carney, W. ( Autor:in ) / Pichon, M.-F. ( Autor:in )
-
Erschienen in:IMMUNOANALYSE ET BIOLOGIE SPECIALISEE ; 19 ; 250-254
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2004
-
Format / Umfang:5 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Französisch
- Neue Suche nach: 574 / 616.97
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 19
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
About the adaptation of french bioethical law and referenceIngrand, J. et al. | 2004
- 3
-
Soluble nucleic acids in whole blood: possible perspectivesLamoril, J. / Bouizegarene, P. / Ameziane, N. / De Prost, D. / Deybach, J. C. et al. | 2004
- 13
-
Molecular biology and cancerBieche, I. et al. | 2004
- 23
-
RNA InterferenceBogard, M. et al. | 2004
- 31
-
Molecular aspects of autoimmune blistering skin diseasesMouquet, H. / Gilbert, D. / Joly, P. / Tron, F. et al. | 2004
- 42
-
Cardiac troponin I and CK-MB following coronary bypass grafting with or without cardiopulmonary bypassCauliez, B. / Redonnet, M. / Darras, S. / Guignery, J. / Marinier, S. / Lavoinne, A. et al. | 2004
- 47
-
Early biochemical detection of pre-eclampsia: the role of placental proteinsBersinger, N. A. / Odegard, R. et al. | 2004
- 54
-
Serological diagnosis of sexually transmitted infection: a critical evaluationEbel, A. / Ly, T. D. / Bianchi, A. et al. | 2004
- 66
-
Factor VII polymorphism R353Q in Tunisian populationMahmoudi, R. / Kallel, C. / Said, F. B. / Hizem, S. / N Siri, B. / Zaeir, M. / Toumi, N. / Mahjoub, T. et al. | 2004
- 71
-
Assessment of specific IgE assay using Immilite® 2000 DPCGuilloux, L. / Hamberger, C. et al. | 2004
- 81
-
Study of a new Elisa method for determination of anti-GAD and anti-IA-2 antibodiesHumbel, R. L. / Bastin, S. / Schmit, P. / Gilson, G. et al. | 2004
- 83
-
Homocysteine and diagnostic tests for thrombophiliasAbecassis, L. / Padin, S. / Soni, T. / Le Bihan, F. et al. | 2004
- 89
-
Utility of cerebrospinal fluid immunofixation of oligoclonal IgG bands in multiple sclerosisVillet, A. M. / Giraud, N. B. / Caudie, C. / Ruel, J.-H. et al. | 2004
- 93
-
Mutation screening of the RB1 gene in 192 retinoblastoma patientsHoudayer, C. / Gauthier-Villars, M. / Dehainault, C. / Pages-Berhouet, S. / Lauge, A. / Caux-Moncoutier, V. / Karczynski, P. / Tosi, M. / Doz, F. / Desjardins, L. et al. | 2004
- 101
-
So the reference values for cTroponin I must be modified in end stage renal disease?Boulier, A. / Bosc, J. Y. / Boularan, A. M. / Canaud, B. / Cristol, J. P. / Dupuy, A. et al. | 2004
- 105
-
Angiotensin II radioimmunoassay in patients with heart failure: methodological and clinical assessmentIervasi, A. / Zucchelli, G. C. / Ripoli, A. / Clerico, A. / Passino, C. / Emdin, M. et al. | 2004
- 110
-
Genotyping in routine laboratory for detection of Factor V Leiden (1691G>A) and Prothrombin (20210G>A) mutations with the Invader® Assay TechnologyHanguehard, A. / Morelle, M. / Turchetto, L. / Depasse, F. / Samama, M. M. / Ronsin, C. et al. | 2004
- 117
-
Screening for alpha-1-antitrypsin genetic variants using Paragon® CZE 2000 capillary electrophoresis systemForay, V. / Chapuis-Cellier, C. et al. | 2004
- 121
-
Gold colloids and electrochemical detection: interest in immunoassays and molecular biologyBrossier, P. / Authier, L. / Dequaire, M. / Grossiord, C. / Vienney, F. et al. | 2004
- 126
-
Separation delays and storage conditions influence on serum total and free prostatic specific antigen assaysOmezzine, A. / Nabli, N. / Rejeb, N. B. / Said, D. B. / Mosbah, A. F. / Bouslama, A. et al. | 2004
- 131
-
New markers of sepsis using proteome analysisStruck, J. / Uhlein, M. / Bergmann, A. et al. | 2004
- 138
-
Immunobiological follow-up for multiple sclerosisBodet, D. / Glaize, G. / Dabadie, M. P. / Geffard, M. et al. | 2004
- 148
-
Carbohydrate deficient transferrin and the% CDT. Detection by capillary electrophoresis with CEofix CDT kit (ANALIS) in moderate alcohol usersLoiseaux, M.-N. / Schwan, R. / Pourignaux, F. / Le Potier, I. / Gengembre, G. et al. | 2004
- 157
-
Interest of the electrophoresis of the alkaline isophosphatase in the insufficient renal hemodialysed patientGillain, N. / Robin, M. / Milet, J. / Minon, J.-M. / Cambier, P. et al. | 2004
- 164
-
Troponin Ic levels in population with high risk for coronary disease: comparison of access and immulite systemBoulier, A. / Terrier, N. / Boularan, A. M. / Gaudard, P. / Colson, P. / Avignon, A. / Descomps, B. / Cristol, J. P. / Dupuy, A. M. et al. | 2004
- 169
-
Difficulty of comparing results of cardiac troponin I about three methods of measurementOrsonneau, J.-L. / Bigot, E. / Delaroche, O. / Dudouet, D. / Loubersac, V. et al. | 2004
- 173
-
Free thyroxine measured with equilibrium dialysis and nine immunoassays in late pregnancySapin, R. / d Herbomez, M. / Schlienger, J. L. et al. | 2004
- 177
-
Prothombin gene: comparative study between PCR-RFLP/Allele specific PCRCoude, M. / Pineau-Vincent, F. et al. | 2004
- 181
-
Luminex™ Technology: technical approach, applications and future prospectsMoalic, V. / Mercier, B. / Ferec, C. et al. | 2004
- 188
-
Metabolic syndrome: comparison of biological parameters among various definitionsLuyckx, F. H. / Scheen, A. J. et al. | 2004
- 195
-
Comparison of techniques used for the detection of specific antibodies against Chlamydia pneumoniaeOrfila, J. / Beaumont, K. / Cabioch, T. / Betsou, F. et al. | 2004
- 201
-
BNP and NT-proBNP: interest in the medical follow-up of top sport peopleDine, G. / Van Lierde, F. et al. | 2004
- 205
-
Diagnostic algorithm of primary CMV infection in pregnant womenMace, M. / Sissoeff, L. / Rudent, A. / Grangeot-Keros, L. et al. | 2004
- 208
-
Interest of measuring Cyfra 21.1 and SCC in the follow-up of patients with treated carcinoma of the head or the neckBanal, A. / Hacene, K. / Berthelot-Ruff, E. / Pichon, M. F. et al. | 2004
- 215
-
Mechanisms and measurement of ageingRobert, L. et al. | 2004
- 219
-
Determination of beta-2-microglobulin in biological samples using immunochemiluminescence or immunoturbidimetry: comparison with radio-immunoassayTerrier, N. / Bonardet, A. / Descomps, B. / Cristol, J. P. / Dupuy, A. M. et al. | 2004
- 225
-
Influence of preanalytical conditions on osteocalcin measurementsde Talance, N. / Genay, K. / Claudon, A. / Burlet, C. et al. | 2004
- 228
-
Evaluation of the new Access®OV Monitor assay for the quantitative determination of CA 125 antigen levelsGandon, G. / Quillien, V. / Godey, F. et al. | 2004
- 235
-
External quality assurance program in anti-HCV serological detection: an Italian experienceVassalle, C. / Mercuri, A. / Masini, S. / Antongiovanni, S. / Pilo, A. / Cantini, F. / Zucchelli, G. C. et al. | 2004
- 241
-
Role of tumoral markers in the biological behaviour of solid tumoursPichon, M.-F. et al. | 2004
- 250
-
Serum Her-2 marker, breast cancer and trastuzumab (Herceptine®)Bethune-Volters, A. / Guepratte, S. / Labroquere, M. / Hacene, K. / Neumann, R. / Carney, W. / Pichon, M.-F. et al. | 2004
- 255
-
Microsatellites alterations before and after primary chemotherapy in locally advanced breast cancersOudin, C. / Picard, S.-F. / Vegran, F. / Franco, N. / Hahnel, L. / Cadouot, M. / Lizard-Nacol, S. et al. | 2004
- 261
-
Chromogranin A in the metastatic cancer of prostatePichon, M.-F. / Hersant, A.-M. / Ferrero-Pous, M. / Floiras, J.-L. / Bresard-Leroy, M. / Pecking, A. et al. | 2004
- 269
-
Positrons Emission Tomography (PET) using ^1^8FDG and occult diseases in cancerology: the experiment of the Rene Huguenin CenterPecking, A. P. / Corone-Mechelany, C. / Alberini, J. L. / Gutman, F. / Sarandi, F. / Bertrand-Kermorgant, F. / Pallud, C. / Floiras, J. L. / Goupil, A. / Pichon, M. F. et al. | 2004
- 274
-
The role of CA 15.3 assays in breast cancerde la Lande, B. et al. | 2004
- 279
-
Markers of digestive cancers: colon, rectum, pancreas, liverEche, N. et al. | 2004
- 286
-
BNP assay on ADVIA Centaur (Bayer HealthCare): correlations with Triage® technique (Biosite) and etiologic application to the diagnosis of a dyspneaBeaune, G. / Mercier-Villet, A. / Steidel, J. / Hominal, S. / Didi, T. / Belle, L. / Lebrun, C. / Jund, J. et al. | 2004
- 294
-
Total ghrelin or active ghrelin? An analytic approachRousseau, C. / Bedel, J. F. / Tounian, A. / Lacorte, J. M. / Clement, K. / Coussieu, C. et al. | 2004
- 301
-
Assessment of monomeric prolactin concentration after serum polyethylene glycol (PEG) precipitationAgin, A. / Gasser, F. / Fischbach, E. / Schlienger, J. L. / Sapin, R. et al. | 2004
- 306
-
Serological tests are instrumental in the diagnosis of rheumatoid arthritis: lessons from a three-year follow-up of 270 patientsYouinou, P. / Renaudineau, Y. / Devauchelle-Pensec, V. / Saraux, A. et al. | 2004
- 311
-
Reflexions in connection with the results obtained on a one day regional tracking of the hepatitis C infectionBodson, A. / Thibe, D. / Rocco, M. / Porolli, J.-C. / Verbelen, V. / Brenard, R. / Guillaume, C. et al. | 2004
- 313
-
Proteomic analysis: benefit and perspective in clinical biologyBaudin, B. / Bruneel, A. et al. | 2004
- 323
-
Rehabilitation of B cells in the genesis of autoimmunityYouinou, P. / Pers, J.-O. / Renaudineau, Y. / Jamin, C. et al. | 2004
- 330
-
Hepatitis B virus genotypesWagner, A. / Denis, F. / Ranger-Rogez, S. / Loustaud-Ratti, V. / Alain, S. et al. | 2004
- 343
-
Spectrum of CFTR mutations in congenital absence of the vas deferensDesideri-Vaillant, C. / Creff, J. / Le marechal, C. / Moalic, V. / Ferec, C. et al. | 2004
- 351
-
Biological parameters used in neonatal systematic cystic fibrosis screening after two years of a national program in FranceDorche, C. / Cheillan, D. / Porst-Chevalier, F. / commission technique de l AFDPHE et al. | 2004
- 357
-
GnRH antagonists and procreation medical assistance (PMA)Belaisch-Allart, J. et al. | 2004
- 360
-
Immunological monitoring cellular and serological evolution for cardiac and kidney transplantsMnasria, K. / Manaa, J. / Machghoul, S. / Gritli, N. / Oueslati, R. et al. | 2004
- 366
-
Serum tumoral markers in ovarian and uterine collar cancersCallet, N. et al. | 2004
- 370
-
The good practices of the medical biology analysis bulletin writingAdeoti, M. F. / Silue, A. / Sawadogo, D. / Dosso, M. / Sess, E. D. et al. | 2004
- 374
-
Good practices for tumoral marker uses: indications, standardization problems, performance of the resultsBasuyau, J.-P. et al. | 2004